Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ligand Pharmaceuticals is a biopharmaceutical company specializing in supporting drug development through licensing, licensing technology, and royalty rights. It focuses on late-stage assets, infrastructure-light platform technologies like Captisol and NITRICIL, and partnerships with leading pharma firms. Revenue streams include royalties, product sales, and milestone payments, with a diversified portfolio aimed at high-margin, low-infrastructure operations in global markets.
This description was generated via AI from an annual report. Updated about 1 year ago.